Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

BUY
$20.09 - $35.8 $730,231 - $1.3 Million
36,348 Added 5.59%
686,449 $14.4 Million
Q2 2022

Aug 15, 2022

BUY
$27.42 - $43.63 $193,859 - $308,464
7,070 Added 1.1%
650,101 $20.2 Million
Q1 2022

May 13, 2022

SELL
$36.48 - $52.22 $122,718 - $175,668
-3,364 Reduced 0.52%
643,031 $26.1 Million
Q4 2021

Feb 11, 2022

SELL
$33.11 - $55.01 $88.2 Million - $146 Million
-2,662,667 Reduced 80.47%
646,395 $27.8 Million
Q3 2021

Nov 12, 2021

SELL
$50.07 - $66.05 $5.48 Million - $7.24 Million
-109,544 Reduced 3.2%
3,309,062 $165 Million
Q2 2021

Aug 13, 2021

BUY
$56.61 - $80.46 $12.1 Million - $17.1 Million
213,050 Added 6.65%
3,418,606 $214 Million
Q1 2021

May 13, 2021

SELL
$86.23 - $125.19 $499,530 - $725,225
-5,793 Reduced 0.18%
3,205,556 $297 Million
Q4 2020

Feb 10, 2021

BUY
$79.17 - $111.47 $21.8 Million - $30.6 Million
274,955 Added 9.36%
3,211,349 $287 Million
Q3 2020

Nov 12, 2020

SELL
$81.91 - $134.94 $4.27 Million - $7.03 Million
-52,079 Reduced 1.74%
2,936,394 $303 Million
Q2 2020

Aug 13, 2020

BUY
$54.33 - $89.52 $34.5 Million - $56.9 Million
635,676 Added 27.02%
2,988,473 $236 Million
Q1 2020

May 14, 2020

SELL
$49.34 - $68.76 $4.84 Million - $6.74 Million
-98,040 Reduced 4.0%
2,352,797 $136 Million
Q4 2019

Feb 12, 2020

BUY
$51.21 - $59.06 $983,385 - $1.13 Million
19,203 Added 0.79%
2,450,837 $132 Million
Q3 2019

Nov 13, 2019

BUY
$40.6 - $57.2 $8.73 Million - $12.3 Million
215,081 Added 9.7%
2,431,634 $127 Million
Q2 2019

Aug 13, 2019

BUY
$39.92 - $53.86 $11.8 Million - $15.9 Million
294,445 Added 15.32%
2,216,553 $107 Million
Q1 2019

May 13, 2019

BUY
$48.23 - $66.16 $29.8 Million - $40.9 Million
617,486 Added 47.33%
1,922,108 $97.1 Million
Q4 2018

Feb 12, 2019

BUY
$55.63 - $73.24 $53.9 Million - $71 Million
969,452 Added 289.24%
1,304,622 $77.3 Million
Q3 2018

Nov 13, 2018

BUY
$52.05 - $66.51 $17.4 Million - $22.3 Million
335,170 New
335,170 $22.1 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $485M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.